Biblio

Author Title Type [ Year

]

Filters: Author is Ke, Qiong [Clear All Filters]

2023

Li G, Yu M, Ke Q, Sun J, Peng Y, Xiong C, Monteiro O, Zhao J, Xiang AP. Enhancement of SARS-CoV-2 vaccine-induced immunity by a Toll-like receptor 7 agonist adjuvant. Signal Transduct Target Ther. 2023;8(1):213.

Xia K, Wang F, Tan Z, Zhang S, Lai X, Ou W, Yang C, Chen H, Peng H, Luo P, et al. Precise Correction of Lhcgr Mutation in Stem Leydig Cells by Prime Editing Rescues Hereditary Primary Hypogonadism in Mice. Adv Sci (Weinh). 2023:e2300993.

2022

Xia K, Wang F, Lai X, Dong L, Luo P, Zhang S, Yang C, Chen H, Ma Y, Huang W, et al. AAV-mediated gene therapy produces fertile offspring in the Lhcgr-deficient mouse model of Leydig cell failure. Cell Rep Med. 2022:100792.

Liang C, Ke Q, Liu Z, Ren J, Zhang W, Hu J, Wang Z, Chen H, Xia K, Lai X, et al. BMAL1 moonlighting as a gatekeeper for LINE1 repression and cellular senescence in primates. Nucleic Acids Res. 2022.

Liu H, Huang S, Wang W, Wang H, Huang W, Zhai Z, Wang D, Fan Y, Sun J, Li D, et al. Migration deficits of the neural crest caused by CXADR triplication in a human Down syndrome stem cell model. Cell Death Dis. 2022;13(12):1018.

2020

Xia K, Ma Y, Feng X, Deng R, Ke Q, Xiang APeng, Deng C. Endosialin defines human stem Leydig cells with regenerative potential. Hum Reprod. 2020.